St Vincent’s Clinic Foundation, has long been a leader in Australian medical research focusing on improving patient care and medical innovation. Similar to the model employed by the Mayo Clinic in the US, the Foundation is a non profit organisation committed to supporting clinic practise, education and research on one campus. Established 30 years ago, the Foundation has since awarded over 400 grants totalling $17 million of support.
With the unprecedented challenges of the COVID-19 pandemic increasing the demands for solutions
to critical and ongoing global health crises, the need for research tod
ay has grown dramatically, particularly in mental health, indigenous health, COVID-19, cancer medicine and rare diseases. Within the context of increasing demand for research funding, St Vincent’s Clinic Foundation has outlined an ambitious plan to increase their annual grant funding from $500,000 to $2M, and are doing so through a refreshed Trustee line up, and a new Capital Campaign.
With an already impressive Board of Trustees including Professor Brett Courtenay OAM, Elizabeth Lewin, Katie Viviers, Leigh Birtles, Mim Haysom, Gail Hambly, Dr Raj Jagavkar, Dr Alan Meagher, Dr Sam Milliken, Edward Harris AC, and Roslyn Packer AC, the Foundation is now adding to its firepower with five new trustees including some of Sydney’s most influential business leaders. Tim Bishop, Michael Coombes, Ray Itaoui, Matthew Miles, and Russell Aboud will be joining the Board of Trustees and bring a wealth of experience and connections in investment banking, real estate, retail, and the NFP sectors.
The Capital Campaign will be inviting 150 Donors to support the Foundation across a range of giving levels and will ensure the Grant corpus will continue to grow to provide a perpetual legacy for the Foundation. And with the Foundation’s low cost base, the campaign promises every dollar donated will go directly to medical research grant funding to support the most promising and imaginative research, and enable better health outcomes and quality of life to as many people as possible.
“It takes innovation, imagination, and investment supporting our research to enable medical breakthroughs that change people’s lives for the better. We are thrilled to be welcoming our new Trustees to help us sustain our dedication to defeating tomorrow’s diseases and illnesses today.”